In the ever-evolving landscape of modern therapeutics, drug targeting has emerged as a pivotal strategy to enhance treatment precision and efficacy. This approach involves directing medications specifically to the site of action, minimizing systemic side effects, and maximizing therapeutic impact. The essence of drug targeting lies in the ability to identify and exploit specific molecular or cellular features associated with a disease. This may include surface receptors, enzymes, or other unique characteristics that distinguish diseased cells from healthy ones. Nanoparticles, liposomes, and antibodies are among the versatile carriers employed in drug delivery systems to ensure the accurate delivery of therapeutic agents. One notable application of drug targeting is in the realm of cancer treatment. By precisely delivering anticancer drugs to malignant cells while sparing healthy tissues, targeted drug delivery minimizes collateral damage and enhances the overall safety of treatment. Additionally, this approach contributes to reducing drug resistance, a common challenge in cancer therapy.
Beyond oncology, drug targeting holds promise in addressing various medical conditions, from inflammatory disorders to infectious diseases. Tailoring drug delivery to specific tissues or cells involved in the pathological process allows for optimized therapeutic outcomes. As we delve deeper into the era of personalized medicine, drug targeting stands out as a cornerstone for achieving treatment precision. The ongoing advancements in nanotechnology, biomaterials, and molecular biology continue to fuel the development of innovative drug delivery systems, bringing us closer to a future where therapies are not only effective but also finely tuned to individual patient needs.
Micro to Nanotechnology based formulations found to play a promising option to develop precise drug targeting. Controlled drug delivery dominated over the conventional drug delivery systems in the…
Participants can earn 1 CPD credit for each hour of attendance.
Oral and poster slots for original Drug Targeting work, reviewed by the scientific committee.
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
In-person and virtual registrations include an electronic copy of the abstract book.
Plenary lectures from leading voices shaping Drug Targeting research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Drug Targeting track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Drug Targeting. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Drug Targeting are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Yes. World Nano 2027 is a hybrid conference — attend the Drug Targeting track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
